Learn more

REVERSE PROTEOMICS RES INST CO

Overview
  • Total Patents
    62
About

REVERSE PROTEOMICS RES INST CO has a total of 62 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets measurement, pharmaceuticals and chemical engineering are OXFORD GENOME SCIENCES UK LTD, DIGILAB INC and PROTEOME SCIENCES PLC.

Patent filings in countries

World map showing REVERSE PROTEOMICS RES INST COs patent filings in countries

Patent filings per year

Chart showing REVERSE PROTEOMICS RES INST COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tanaka Akito 35
#2 Yamazaki Akira 25
#3 Haramura Masayuki 20
#4 Suwa Yorimasa 15
#5 Terada Tomohiro 13
#6 Yamauchi Tadakazu 10
#7 Kito Morikazu 10
#8 Isogai Takao 10
#9 Tsutsumi Takeshi 9
#10 Tamura Tsuruki 9

Latest patents

Publication Filing date Title
WO2008123266A1 Target protein and target gene for drug discovery, and screening method
WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation
WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation
WO2008114672A1 Cancer-specific biomarker
WO2008102912A1 Target protein and target gene for drug discovery, and screening method
JP2008174495A Target protein and target gene for use in drug development and method for screening the same
WO2007026969A1 Drug target protein and target gene, and screening method
US2010094026A1 Method of screening compound useful in treating allergic disease
WO2006101272A1 Target protein and target gene for drug discovery and screening method
WO2006080559A1 Method for effective search for target molecule
WO2006052000A1 Target protein and target gene in drug designing and screening method
WO2006043710A1 Drug development target protein and target gene, and method of screening
WO2006043691A1 Target protein and target gene in drug designing and screening method
WO2006011673A1 Solid support having ligand immobilized thereon by using photocleavable linker
WO2005115468A1 Novel drug discovery target and medicine acting on the same
WO2005054216A1 Novel anticancer agent “sulcoxin”
EP1690852A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto
WO2005054468A1 Target protein of antidiabetic agent and novel antidiabetic agent “insuful” corresponding thereto
US2007122913A1 Method of calibrating ligand specificity
EP2110393A1 Affinity resin